Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexuprazan Maintenance Therapy in Healed Erosive Esophagitis
NCT04341428Phase 3Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fexuprazan in erosive esophagitis (EE), sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
fexuprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT04341428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341428.